Clomiphene (Clomid): A Tracking Guide for the Fertility SERM

Clomiphene (Clomid) is a SERM long used to induce ovulation in women and, off-label, to raise testosterone and support fertility in men by stimulating the pituitary to release more LH and FSH. It is a common component of post-cycle therapy and of clinical protocols for secondary hypogonadism.

This is an educational tracking guide. Clomiphene is prescription-only. Its distinctive warnings - visual disturbances and, in fertility settings, ovarian hyperstimulation - shape what you monitor.

What it does

• Blocks estrogen receptors at the hypothalamus and pituitary, which the body reads as low estrogen
• In response, LH and FSH rise, stimulating the gonads
• In men, this raises endogenous testosterone and supports sperm production
• In women, it triggers ovulation

What people use it for

• Male fertility and raising natural testosterone (an alternative to TRT for some)
• Post-cycle HPTA recovery
• Female ovulation induction (clinical setting)

What to track daily

• Dose, timing
• Mood - clomiphene mood effects are commonly reported
• Libido and erectile function (men)
• Visual disturbances: blurring, floaters, light sensitivity, trails - stop and seek care if these appear
• Energy and well-being
• For fertility patients, any abdominal swelling or pain (OHSS warning in women)

What to track weekly

• Subjective well-being, mood, libido trend
• Side-effect accumulation, especially visual symptoms

Bloodwork worth doing

• Baseline: LH, FSH, total and free testosterone, sensitive estradiol (men); cycle-appropriate hormones (women)
• Follow-up at 4-6 weeks: confirm LH, FSH, and testosterone are responding
• Estradiol can rise as testosterone rises; trend it

Realistic expectations

• Testosterone and LH and FSH typically rise within weeks when it works
• Mood side effects are a real and common reason people stop
• Visual disturbances, though uncommon, are a recognised reason to discontinue

Common mistakes

• Ignoring or pushing through visual symptoms
• Dismissing mood changes
• No follow-up bloods to confirm it is actually working
• Assuming it works equally well for everyone (response varies)

A tracking template

• Pre: baseline LH, FSH, testosterone, estradiol
• On: daily mood, libido, and crucially visual-symptom logs
• Follow-up: recheck hormone panel at 4-6 weeks

Safety notes

Recognised risks include visual disturbances (a reason to stop) and, in fertility settings in women, ovarian hyperstimulation syndrome. Mood changes are common. Prescription-only; use under a physician, and report visual changes promptly.

Peptide IA is an educational and self-tracking tool. Nothing in this post is medical advice. Doses mentioned reflect what is commonly reported in research literature — they are not recommendations. Always consult a qualified physician before starting, changing, or stopping any protocol.